Key facts
- Advancements in medicine have been reported over the past five weeks.
- News has emerged regarding retatrutide, identified as a triple agonist.
The past month has been characterized by notable progress in the medical field, with specific mention of a new drug candidate, retatrutide. This development suggests ongoing innovation and potential breakthroughs in therapeutic treatments.